ClinicalTrials.gov
public full text
Public Domain
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors
breast-cancerlung-cancerovarian-cancerprostate-cancerprotocol-specificsarcomaunspecified-adult-solid-tumor
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors predict how well patients will respond to treatment. It may also help the study of cancer in the future. PURPOSE: This laboratory study is looking at blood samples from patients receiving trastuzumab and/or chemotherapy for HER2-positive solid tumors to assess T-cell response.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Circulating Tumour Cells in Patients With Peritoneal Metastases#995281
- Immune Response in Peripheral Blood of Patients With Colon Cancer#1164119
- Feasibility of a New Technology for Isolating Circulating Tumour Cells#884624
- Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes#838277
- T-cell Developmental Status in Patients With Malignant Hematological Tumors#878742
Record · ID 1125445
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive